Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

DURECT Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Apr 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - DURECT Corp (DRRX-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

27 May 2016 Thomson Reuters Stock Report 12 $25.00

DURECT Corp. : Remoxy Could Capture More of OxyContin Market

The following is an excerpt from the Streetwise Reports interview with George Zavoico, Senior Equity Analyst at JonesTrading ...

12 May 2016 Streetwise Reports 2 $12.00

DURECT Corp. : Posimir Has Proven Market Potential

The following is an excerpt from the Streetwise Reports interview with Jim Molloy, Analyst with Laidlaw & Co. analyst, "From ...

12 May 2016 Streetwise Reports 2 $12.00

Durect Corporation (DRRX, BUY, $4 PT) Posimir a 2017 Event as DUR-928 Takes 2016 Center Stage

Durect reported 1Q16 in-line with our expectations as it remains a development and not an earning story. Partner Pain Therap...

09 May 2016 Laidlaw & Company 9 $25.00

DURECT Corporation (DRRX) - Financial and Strategic SWOT Analysis Review

DURECT Corporation (DRRX) - Financial and Strategic SWOT Analysis Review Summary DURECT Corporation (Durect) is a specialty p...

06 May 2016 GlobalData 72 $300.00

Thomson Reuters Stock Report - DURECT Corp (DRRX-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

05 May 2016 Thomson Reuters Stock Report 12 $25.00

DRRX: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

05 May 2016 New Constructs, LLC 10 $25.00

ValuEngine Rating and Forecast Report for DRRX

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

01 May 2016 ValuEngine, Inc. 11 $25.00

DURECT Corp

30 Apr 2016 S&P Capital IQ Quantitative Report 9 $104.00